Amaryl and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amaryl (glimepiride) and Zoledronic acid (zoledronic acid). Common drug interactions include anaemia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Amaryl and Zoledronic acid. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.



On Jul, 16, 2026

19 people who take Amaryl and Zoledronic acid together, and have interactions are studied.

Amaryl and Zoledronic acid drug interactions.

What are the common drug interactions of Amaryl and Zoledronic Acid, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Pain
  3. Dry mouth
  4. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  5. Chronic kidney disease
  6. Compression fracture (fracture due to pressure caused by injury)
  7. Disease progression
  8. Haemorrhage (bleeding)
  9. Iron deficiency anaemia
  10. Osteoporosis (bones weak and more likely to break)

male:

  1. Pneumonia
  2. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Back pain
  5. Blood sodium decreased
  6. Bowel movement irregularity
  7. C-reactive protein increased
  8. Compression fracture (fracture due to pressure caused by injury)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Decreased activity

What are the common drug interactions of Amaryl and Zoledronic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diarrhoea
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Fungal infection
  6. Hyperchlorhydria (gastric acid levels are higher in stomach)
  7. Limb discomfort (discomfort in leg)
  8. Muscle spasms (muscle contraction)
  9. Neoplasm progression (growth of tumour)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

  1. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  2. Pneumonia
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Pain
  2. Anaemia (lack of blood)
  3. Chronic kidney disease
  4. Compression fracture (fracture due to pressure caused by injury)
  5. Disease progression
  6. Dry mouth
  7. Haemorrhage (bleeding)
  8. Iron deficiency anaemia
  9. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Anaemia (lack of blood)
  2. Compression fracture (fracture due to pressure caused by injury)
  3. Plasma cell myeloma (cancer that begins in plasma cells)
  4. Neoplasm malignant (cancer tumour)
  5. Visual impairment
  6. Confusional state
  7. Pneumonia
  8. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  9. Albumin urine present
  10. Angioedema (rapid swelling of the dermis)

What are the existing conditions these people have? *

  1. Neuropathy Peripheral (surface nerve damage): 9 people, 47.37%
  2. Pain: 9 people, 47.37%
  3. Dyspnea (difficult or laboured breathing): 8 people, 42.11%
  4. Nausea (feeling of having an urge to vomit): 8 people, 42.11%
  5. Wheezing (a high-pitched whistling sound made while you breath): 8 people, 42.11%
  6. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 31.58%
  7. Thalamic Infarction (tissue death of thalamus part of brain): 6 people, 31.58%
  8. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 5 people, 26.32%
  9. Swelling: 5 people, 26.32%
  10. Muscle Spasms (muscle contraction): 5 people, 26.32%

* Approximation only. Some reports may have incomplete information.

Do you take Amaryl and Zoledronic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amaryl and Zoledronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zoledronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amaryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zoledronic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride and zoledronic acid (the active ingredients of Amaryl and Zoledronic acid, respectively), and Amaryl and Zoledronic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: